Act Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Act Capital Management, LLC disclosed 62 US equity positions worth $153.1m in its Q2 2026 13F filing. The largest position was KRYS at 10.9% of the reported book, followed by TGTX and ABVX. Against the Q1 2026 filing, it opened 17 new positions, added to 14 and reduced 10 among the top 50 holdings.
What did Act Capital Management, LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | KRYS KRYSTAL BIOTECH INC | Healthcare | 10.9% | $16.7m | 45,000 | -26% | reduced |
| 2 | TGTX TG THERAPEUTICS INC | Healthcare | 9.0% | $13.8m | 251,025 | 1% | added |
| 3 | ABVX ABIVAX SA | Healthcare | 8.4% | $12.9m | 97,000 | 37% | added |
| 4 | CVX CHEVRON CORP | Energy | 8.1% | $12.4m | 75,000 | 0% | held |
| 5 | EXMOC EXXON MOBIL CORP | 7.0% | $10.7m | 78,500 | 12% | added | |
| 6 | ARWR ARROWHEAD PHARMACEUTICALS INC | Healthcare | 5.9% | $9.0m | 110,100 | 33% | added |
| 7 | VKTX VIKING THERAPEUTICS INC | Healthcare | 5.3% | $8.2m | 209,300 | 0% | held |
| 8 | CELC CELCUITY INC | Healthcare | 4.2% | $6.5m | 62,150 | -32% | reduced |
| 9 | NKTR NEKTAR THERAPEUTICS | Healthcare | 4.1% | $6.2m | 89,300 | 26% | added |
| 10 | TSLA TESLA INC | Consumer Cyclical | 3.0% | $4.5m | 10,800 | – | new |
| 11 | CYTK CYTOKINETICS INC | Healthcare | 2.6% | $4.0m | 47,500 | -26% | reduced |
| 12 | ASTS AST SPACEMOBILE INC | Technology | 2.5% | $3.9m | 43,500 | – | new |
| 13 | PVLA PALVELLA THERAPEUTICS INC | Healthcare | 2.2% | $3.4m | 22,500 | – | new |
| 14 | AMZN AMAZON.COM INC | Consumer Cyclical | 2.0% | $3.1m | 12,900 | -61% | reduced |
| 15 | NUVB NUVATION BIO INC | Healthcare | 1.9% | $3.0m | 520,000 | 79% | added |
| 16 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.9% | $2.9m | 48,000 | 43% | added |
| 17 | ET ENERGY TRANSFER L P | Energy | 1.7% | $2.5m | 133,100 | 0% | held |
| 18 | BE BLOOM ENERGY CORP | Industrials | 1.5% | $2.3m | 7,500 | 67% | added |
| 19 | FCX FREEPORT-MCMORAN INC | Basic Materials | 1.3% | $2.0m | 32,500 | -16% | reduced |
| 20 | NBIS NEBIUS GROUP NV | Communication Services | 1.2% | $1.9m | 6,800 | – | new |
| 21 | ALMS ALUMIS INC | Healthcare | 0.9% | $1.5m | 51,600 | -70% | reduced |
| 22 | AMBA AMBARELLA INC | Technology | 0.9% | $1.4m | 16,000 | – | new |
| 23 | CBRS CEREBRAS SYSTEMS INC | Technology | 0.8% | $1.2m | 5,600 | – | new |
| 24 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 0.8% | $1.2m | 25,000 | – | new |
| 25 | NOK NOKIA CORP | Technology | 0.7% | $1.1m | 82,000 | – | new |
| 26 | KURA KURA ONCOLOGY INC | Healthcare | 0.6% | $975.2k | 88,900 | 20% | added |
| 27 | PRAX PRAXIS PRECISION MEDICINES INC | Healthcare | 0.6% | $903.9k | 2,700 | 0% | held |
| 28 | AAOI APPLIED OPTOELECTRONICS INC | Technology | 0.6% | $889.0k | 6,000 | -77% | reduced |
| 29 | CCJ CAMECO CORP | Energy | 0.6% | $855.6k | 8,400 | – | new |
| 30 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 0.6% | $847.0k | 35,000 | 56% | added |
| 31 | RGNX REGENXBIO INC | Healthcare | 0.5% | $808.6k | 67,500 | 21% | added |
| 32 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.5% | $758.1k | 28,100 | – | new |
| 33 | GBTC GRAYSCALE BITCOIN TRUST ETF | 0.5% | $701.0k | 15,400 | 0% | held | |
| 34 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.4% | $655.2k | 64,300 | 0% | held |
| 35 | PALI PALISADE BIO INC | Healthcare | 0.4% | $642.7k | 307,500 | 19% | added |
| 36 | PLTR PALANTIR TECHNOLOGIES INC | Technology | 0.4% | $641.7k | 5,500 | – | new |
| 37 | ON ON SEMICONDUCTOR CORP | Technology | 0.4% | $567.2k | 6,000 | – | new |
| 38 | HCC WARRIOR MET COAL INC | Basic Materials | 0.3% | $487.0k | 6,000 | 0% | held |
| 39 | CRGY CRESCENT ENERGY COMPANY | Energy | 0.3% | $441.9k | 45,000 | 0% | held |
| 40 | MBX MBX BIOSCIENCES INC | Healthcare | 0.3% | $441.6k | 8,000 | -11% | reduced |
| 41 | KEEL KEEL INFRASTRUCTURE CORP | Technology | 0.3% | $427.6k | 74,500 | – | new |
| 42 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.3% | $424.5k | 30,000 | 94% | added |
| 43 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 0.3% | $403.4k | 27,000 | – | new |
| 44 | ALPHA COGNITION INC | 0.2% | $371.8k | 51,500 | 0% | held | |
| 45 | KYTX KYVERNA THERAPEUTICS INC | 0.2% | $356.4k | 40,000 | 33% | added | |
| 46 | AXTI AXT INC | Technology | 0.2% | $353.2k | 4,900 | – | new |
| 47 | INFQ INFLEQTION INC | 0.2% | $333.0k | 25,000 | – | new | |
| 48 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.2% | $330.0k | 6,000 | -44% | reduced |
| 49 | PATH UIPATH INC | Technology | 0.2% | $326.1k | 30,000 | -40% | reduced |
| 50 | ANL ADLAI NORTYE LTD | 0.2% | $310.5k | 27,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.